Indeed, a highly significant enrichment of p16 transcripts ( CDKN2A ) was detectable in patients with CRC compared to normal tissue (Fig. 7 A).
← all excerpts
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistance.
1
—
—